Table 1. Relationship between Syk mRNA expression and clinicopathologic characteristics in 31 OSCC tissue samples.

Characteristics	n (%)	Relative expression of Syka	Pb
Gender
Male	18(58)	1.42 (0.91-5.09)
Female	13(42)	3.72 (1.93-4.25)	0.3045
Age (y)
<60	13(42)	1.56 (0.95-5.01)
≥60	18(58)	2.57 (1.08-4.35)	0.9764
Pathologic stage
I,II	26(81)	2.57 (1.14-4.42)
III,IV	5(19)	0.98 (0.59-5.89)	0.5087
T classificationc
T1-2	19(61)	2.78 (1.47-4.18)
T3-4	8(25)	1.04 (0.62-4.62)	0.0926
Lymph node metastasis
N0	17(55)	2.36 (0.99-4.20)
N1	4(13)	0.88 (0.50-1.97)
N2	10(32)	4.29 (1.54-6.49)	0.0219
Clinical stagec
I,II	12(39)	2.80 (1.14-4.14)
III,IV	15(48)	1.56 (0.98-4.85)	0.6572
Recurrence
No	27(87)	2.30 (1.06-4.18)
Yes	4(13)	4.25 (1.74-5.67)	0.3414

^aMedian of relative expression (25% percentile-75% Percentile).

^bMann-Whitney U test between two groups and Kruskall-Wallis test for 3 groups.

^cThe recurrent patients were not grouped by T classification and Clinical stage.